Health-related quality of life as a prognostic factor in patients with advanced cancer

Cancer

Volumn 120, Issue 23, 2014, Pages 3717-3721

  Steel, Jennifer L ^a,b   Geller, David A ^a   Robinson, Tiana L ^a   Savkova, Alexandra Y ^a   Brower, Deborah S ^a   Marsh, J Wallis ^a   Tsung, Allan ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced cancer; Cholangiocarcinoma; Hepatocellular carcinoma; Palliative care; Quality of life; Survival

Indexed keywords

YTTRIUM 90;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; DEMOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY HEPATOBILIARY INSTRUMENT; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT CODING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; BILE DUCT TUMOR; COHORT ANALYSIS; HEALTH STATUS; INTRAHEPATIC BILE DUCT; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 84913607872     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28902     Document Type: Article

References (28)

1. Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer. 1990; 62:695-699.
2. Lis CG, Gupta D, Granick J., Grutsch JF. Can patient satisfaction with quality of life predict survival in advanced colorectal cancer?. Support Care Cancer. 2006; 14:1104-1110.
3. Meyers CA, Hess KR, Yung W.K., Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol. 2000; 18:646-650.
4. Park SM, Park MH, Won J.H., et al. EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units. Support Care Cancer. 2006; 14:329-333.
5. Poon RT, Fan ST, Yu W.C., Lam BK, Chan FY, Wong J. A prospective longitudinal study of quality of life after resection of hepatocel-lular carcinoma. Arch Surg. 2001; 136:693-699.
6. Narkush RE, Schwab JJ, Farris P, Present P.A., Holzer CE 3rd. Mortality and community mental health. The Alachua County, Florida, mortality study. Arch Gen Psychiatry. 1977; 34:1393-1401.
7. Coates A, Forbes J, Simes RJ. Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group. J Clin Oncol. 1993; 11:2050.
8. Coates A, Gebski V, Signorini D., et al. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. J Clin Oncol. 1992; 10:1833-1838.
9. Kramer JA, Curran D, Piccart M., et al. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer. 2000; 36:1498-1506.
10. Sullivan PW, Nelson JB, Mulani P.M., Sleep D. Quality of life as a potential predictor for morbidity and mortality in patients with met-astatic hormone-refractory prostate cancer. Qual Life Res. 2006; 15: 1297-1306.
11. Dancey J, Zee B, Osoba D., et al. Quality of life scores: an independent prognostic variable in a general population of cancer patients receiving chemotherapy. The National Cancer Institute of Canada Clinical Trials Group. Qual Life Res. 1997; 6:151-158.
12. Ringdal GI, Ringdal K, Kvinnsland S., Gotestam KG. Quality of life of cancer patients with different prognoses. Qual Life Res. 1994; 3: 143-154.
13. Di Bisceglie AM, Carithers RL Jr, Gores GJ. Hepatocellular carcinoma. Hepatology. 1998; 28:1161-1165.
14. Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients" subjective experience of disease and psychosocial well-being. Radiother Oncol. 1989; 15:235-242.
15. el-Serag HB, Kunik M, Richardson P., Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002; 123:476-482.
16. Rumsfeld JS, MaWhinney S, McCarthy M Jr, et al. Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Affairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA. 1999; 281:1298-1303.
17. Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000; 55:19-25.
18. Dharma-Wardene M, Au HJ, Hanson J, Dupere D., Hewitt J, Feeny D. Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res. 2004; 13:1209-1216.
19. Herndon JE 2nd, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999; 85:333-340.
20. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993; 11:570-579.
21. Heffernan N, Cella D, Webster K., et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol. 2002; 20:2229-2239.
22. Kaplan GA, Reynolds P. Depression and cancer mortality and morbidity: prospective evidence from the Alameda County study J Behav Med. 1988; 11:1-13.
23. Dantzer R. Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun. 2001; 15:7-24.
24. Steel JL, Geller DA, Gamblin T.C., Olek MC, Carr BI. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 2007; 25:2397-2405.
25. Bruce ML, Leaf PJ, Rozal G.P., Florio L., Hoff RA. Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry. 1994; 151:716-721.
26. Huppert FA, Whittington JE. Symptoms of psychological distress predict 7-year mortality. Psychol Med. 1995; 25:1073-1086.
27. Somervell PD, Kaplan BH, Heiss G, Tyroler H.A., Kleinbaum DG, Obrist PA. Psychologic distress as a predictor of mortality. Am J Epidemiol. 1989; 130:1013-1023.
28. Simonsick EM, Wallace RB, Blazer D.G., Berkman LF. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med. 1995; 57:427-435.